Clofarabine-induced Capillary Leak Syndrome in a Child With Refractory Acute Lymphoblastic Leukemia


Baytan B., Ozdemir O., Gunes A. M. , DÖNMEZ O.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, vol.32, no.2, pp.144-146, 2010 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 2
  • Publication Date: 2010
  • Doi Number: 10.1097/mph.0b013e3181bf298b
  • Title of Journal : JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
  • Page Numbers: pp.144-146

Abstract

Clofarabine has significant efficiency in children with relapsed or refractory leukemia. In previous pediatric trials, various adverse effects have been described. In this case, we report a child with refractory acute lymphoblastic leukemia who developed fatal capillary leak syndrome during clofarabine therapy.